{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T05:54:46Z","timestamp":1757310886393,"version":"3.37.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2009,2,13]],"date-time":"2009-02-13T00:00:00Z","timestamp":1234483200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1007\/s10072-009-0023-0","type":"journal-article","created":{"date-parts":[[2009,2,12]],"date-time":"2009-02-12T22:24:58Z","timestamp":1234477498000},"page":"259-262","source":"Crossref","is-referenced-by-count":12,"title":["Widely varying TNF-\u03b1 levels in patients with myasthenia gravis"],"prefix":"10.1007","volume":"30","author":[{"given":"Jin Soo","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In Soo","family":"Joo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung Im","family":"Seok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,2,13]]},"reference":[{"key":"23_CR1","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM199406233302507","volume":"330","author":"DC Drachman","year":"1994","unstructured":"Drachman DC (1994) Myasthenia gravis. N Engl J Med 330:1797\u20131810","journal-title":"N Engl J Med"},{"key":"23_CR2","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/978-1-59259-129-9_15","volume-title":"Cytokines and autoimmune diseases","author":"P Christadoss","year":"2002","unstructured":"Christadoss P, Goluszko E (2002) Myasthenia gravis. In: Sarvetnick N, Hafler DA, Kuchroo VK (eds) Cytokines and autoimmune diseases. Hamana Press, Totowa, pp 373\u2013385"},{"key":"23_CR3","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0165-5728(01)00473-8","volume":"122","author":"P Christadoss","year":"2002","unstructured":"Christadoss P, Goluszko E (2002) Treatment of experimental autoimmune myasthenia gravis with recombinant human tumor necrosis factor receptor Fc protein. J Neuroimmunol 122:186\u2013190","journal-title":"J Neuroimmunol"},{"key":"23_CR4","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1006\/jaut.2002.0618","volume":"19","author":"RS Duan","year":"2002","unstructured":"Duan RS, Wang HB, Yang JS, Scallon B, Link H, Xiao BG (2002) Anti-TNF-alpha antibodies suppress the development of experimental autoimmune myasthenia gravis. J Autoimmun 19:169\u2013174","journal-title":"J Autoimmun"},{"key":"23_CR5","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1056\/NEJM198703193161205","volume":"316","author":"RS Tindall","year":"1987","unstructured":"Tindall RS, Rollins JA, Phillips JT, Greenlee RG, Wells L, Belendiuk G (1987) Preliminary results of a double-blind, randomized, placebo-controlled trial of cyclosporine in myasthenia gravis. N Engl J Med 316:719\u2013724","journal-title":"N Engl J Med"},{"key":"23_CR6","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1212\/WNL.26.11.1054","volume":"26","author":"JM Lindstorm","year":"1976","unstructured":"Lindstorm JM, Seybold ME, Lennon VA, Whittingham S, Duane DD (1976) Antibody to acetylcholine receptor in myasthenia gravis: prevalence, clinical correlates, and diagnostic value. Neurology 26:1054\u20131059","journal-title":"Neurology"},{"key":"23_CR7","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/(SICI)1097-4598(199705)20:5<543::AID-MUS2>3.0.CO;2-9","volume":"20","author":"GX Zhang","year":"1997","unstructured":"Zhang GX, Navikas V, Link H (1997) Cytokines and the pathogenesis of myasthenia gravis. Muscle Nerve 20:543\u2013551","journal-title":"Muscle Nerve"},{"key":"23_CR8","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0090-1229(91)90115-Q","volume":"60","author":"RE Ahlberg","year":"1991","unstructured":"Ahlberg RE, Pirskanen R, Lefvert AK (1991) Defective T lymphocyte function in nonthymectomized patients with myasthenia gravis. Clin Immunol Immunopathol 60:93\u2013105","journal-title":"Clin Immunol Immunopathol"},{"key":"23_CR9","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1600-0404.2006.00778.x","volume":"115","author":"M Kakoulidou","year":"2007","unstructured":"Kakoulidou M, Bjelak S, Pirskanen R, Lefvert AK (2007) A clinical and immunological study of a myasthenia gravis patient treated with infliximab. Acta Neurol Scand 115:279\u2013283","journal-title":"Acta Neurol Scand"},{"key":"23_CR10","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1212\/01.WNL.0000147242.92691.71","volume":"63","author":"J Rowin","year":"2004","unstructured":"Rowin J, Meriggioli MN, Tuzun E, Leurgans S, Christadoss P (2004) Etanercept treatment in corticosteroid-dependent myasthenia gravis. Neurology 63:2390\u20132392","journal-title":"Neurology"},{"key":"23_CR11","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jaut.2005.01.013","volume":"24","author":"E T\u00fcz\u00fcn","year":"2005","unstructured":"T\u00fcz\u00fcn E, Meriggioli MN, Rowin J, Yang H, Christadoss P (2005) Myasthenia gravis patients with low plasma IL-6 and IFN-gamma benefit from etanercept treatment. J Autoimmun 24:261\u2013268","journal-title":"J Autoimmun"},{"key":"23_CR12","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1212\/WNL.33.10.1316","volume":"33","author":"UA Besinger","year":"1983","unstructured":"Besinger UA, Toyka KV, Homberg M, Heininger K, Hohlfeld R, Fateh-Moghadam A (1983) Myasthenia gravis: long-term correlation of binding and bungarotoxin blocking antibodies against acetylcholine receptors with changes in disease severity. Neurology 33:1316\u20131321","journal-title":"Neurology"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-009-0023-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10072-009-0023-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-009-0023-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T17:23:25Z","timestamp":1738949005000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10072-009-0023-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,13]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["23"],"URL":"https:\/\/doi.org\/10.1007\/s10072-009-0023-0","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"type":"print","value":"1590-1874"},{"type":"electronic","value":"1590-3478"}],"subject":[],"published":{"date-parts":[[2009,2,13]]}}}